Messenger RNA vaccines against SARS-CoV-2.
Cell
; 184(6): 1401, 2021 03 18.
Article
in English
| MEDLINE | ID: covidwho-1030852
ABSTRACT
The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3-4 weeks apart. To view this Bench to Bedside, open or download the PDF.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines, Synthetic
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Cell
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS